Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

Last Close
Nov 11 04:00PM ET
19.97
Dollar change
+0.30
Percentage change
1.53
%
Index- P/E9.79 EPS (ttm)2.04 Insider Own1.82% Shs Outstand162.45M Perf Week4.39%
Market Cap3.24B Forward P/E9.98 EPS next Y2.00 Insider Trans-2.85% Shs Float159.48M Perf Month1.73%
Income- PEG1.96 EPS next Q0.51 Inst Own27.26% Short Float4.06% Perf Quarter11.44%
Sales494.41M P/S6.56 EPS this Y-2.40% Inst Trans- Short Ratio7.82 Perf Half Y5.06%
Book/sh11.56 P/B1.73 EPS next Y-2.00% ROA- Short Interest6.48M Perf Year28.56%
Cash/sh- P/C- EPS next 5Y5.00% ROE- 52W Range14.95 - 21.69 Perf YTD21.32%
Dividend Est.1.60 (8.01%) P/FCF- EPS past 5Y11.01% ROI- 52W High-7.93% Beta1.33
Dividend TTM1.59 (7.96%) Quick Ratio- Sales past 5Y- Gross Margin- 52W Low33.58% ATR (14)0.35
Dividend Ex-DateNov 13, 2024 Current Ratio- EPS Y/Y TTM45.84% Oper. Margin- RSI (14)55.21 Volatility2.10% 1.63%
Employees100 Debt/Eq- Sales Y/Y TTM30.92% Profit Margin- Recom2.40 Target Price20.64
Option/ShortYes / Yes LT Debt/Eq- EPS Q/Q145.70% Payout83.29% Rel Volume2.06 Prev Close19.67
Sales Surprise-2.27% EPS Surprise-0.23% Sales Q/Q7.30% EarningsOct 30 AMC Avg Volume828.50K Price19.97
SMA200.66% SMA501.83% SMA2004.47% Trades Volume1,705,148 Change1.53%
Date Action Analyst Rating Change Price Target Change
Jan-16-24Downgrade Compass Point Buy → Neutral $17 → $17.50
Nov-21-23Initiated UBS Neutral $17
Aug-30-23Upgrade Compass Point Neutral → Buy $17.50
Aug-04-23Upgrade Keefe Bruyette Underperform → Mkt Perform $13.50 → $17
Apr-06-23Upgrade Piper Sandler Neutral → Overweight $16
Mar-13-23Downgrade Keefe Bruyette Mkt Perform → Underperform $14.50 → $10.50
Jul-29-22Downgrade Oppenheimer Outperform → Perform
Apr-22-22Downgrade Keefe Bruyette Outperform → Mkt Perform $18
Apr-04-22Downgrade Piper Sandler Overweight → Neutral $19
Feb-08-22Downgrade Compass Point Buy → Neutral $18
Today 10:38AM
Nov-09-24 05:51AM
Nov-08-24 08:30AM
Oct-31-24 01:01PM
11:24AM
03:17AM Loading…
03:17AM
Oct-30-24 08:00PM
06:35PM
05:33PM
04:07PM
Oct-28-24 09:16AM
06:00AM
Oct-22-24 06:15PM
Oct-20-24 06:24AM
Oct-17-24 06:00AM
06:15PM Loading…
Oct-16-24 06:15PM
Oct-12-24 05:26AM
Oct-09-24 06:15PM
03:53PM
06:00AM
Oct-01-24 06:15PM
Sep-25-24 06:15PM
06:00AM
Sep-21-24 07:53AM
Sep-19-24 06:15PM
Sep-13-24 06:00PM
Sep-09-24 08:55PM
Aug-28-24 02:33PM
Aug-27-24 04:05PM
Aug-23-24 04:00PM
03:23AM Loading…
03:23AM
03:03AM
Aug-21-24 05:59AM
Aug-19-24 04:05PM
Aug-16-24 09:44PM
Aug-13-24 04:00PM
11:09AM
Aug-12-24 04:39AM
Aug-08-24 11:28PM
Aug-02-24 07:56AM
Aug-01-24 07:00PM
05:50PM
04:47PM
04:07PM
Jul-31-24 11:00AM
Jul-30-24 12:13PM
06:00AM
Jul-29-24 09:16AM
Jul-23-24 06:15PM
Jul-22-24 04:07AM
Jul-19-24 09:40AM
Jul-18-24 06:00AM
Jul-17-24 06:15PM
09:00AM
06:00AM
Jul-11-24 06:15PM
06:45AM
Jun-27-24 06:15PM
09:30AM
05:45AM
Jun-24-24 06:45AM
Jun-22-24 03:43AM
03:43AM
03:43AM
Jun-21-24 06:15PM
Jun-14-24 06:00PM
03:39AM
Jun-13-24 06:15PM
07:00AM
Jun-08-24 05:29AM
Jun-07-24 06:00PM
Jun-06-24 06:15AM
Jun-02-24 02:42PM
05:21AM
03:01AM
May-23-24 11:49AM
04:21AM
May-17-24 01:36PM
10:33AM
May-16-24 08:18AM
May-15-24 11:07AM
07:00AM
May-14-24 08:00AM
May-13-24 06:00AM
May-09-24 08:20AM
07:00AM
06:30AM
May-07-24 06:00AM
04:34AM
May-05-24 05:17AM
May-03-24 12:57PM
11:22AM
07:12AM
May-02-24 09:56PM
07:30PM
06:01PM
04:57PM
04:05PM
Apr-30-24 08:30AM
06:00AM
Hercules Capital, Inc. is a business development company. The firm specializing in providing private equity, venture debt, and growth capital to privately held venture capital-backed companies at all stages of development from mid venture to expansion stage including select publicly listed companies and select special opportunity companies that require additional capital to fund acquisitions, recapitalizations and refinancing and established-stage companies. The firm provides growth capital financing solutions for capital extension; management buy-out and corporate spin-out financing solutions; company, asset specific, or intellectual property acquisition financing; convertible, subordinated and/or mezzanine loans; domestic and international corporate expansion; vendor financing; revenue acceleration by sales and marketing development, and manufacturing expansion. It provides asset-based financing with a focus on cash flow; accounts receivable facilities; equipment loans or leases; equipment acquisition; facilities build-out and/or expansion; working capital revolving lines of credit; inventory. The firm also provides bridge financing to IPO or mergers and acquisitions or technology acquisition; dividend recapitalizations and other sources of investor liquidity; cash flow financing to protect against share price volatility; competitor acquisition; pre-IPO financing for extra cash on the balance sheet; public company financing to continue asset growth and production capacity; short-term bridge financing; and strategic and intellectual property acquisition financings. It also focuses on customized financing solutions, emerging growth, mid venture, and late venture financing. The firm invests primarily in structured debt with warrants and, to a lesser extent, in senior debt and equity investments. The firm generally seeks to invest in companies that have been operating for at least six to 12 months prior to the date of their investment. It prefers to invest in technology, SaaS Finance, energy technology, sustainable and renewable technology, and life sciences. Within technology the firm focuses on advanced specialty materials and chemicals; communication and networking, consumer and business products; consumer products and services, digital media and consumer internet; electronics and computer hardware; enterprise software and services; gaming; healthcare services; information services; business services; media, content and information; mobile; resource management; security software; semiconductors; semiconductors and hardware; and software sector. Within energy technology, it invests in agriculture; clean technology; energy and renewable technology, fuels, and power technology; geothermal; smart grid and energy efficiency and monitoring technologies; solar; and wind. Within life sciences, the firm invests in biopharmaceuticals; biotechnology tools; diagnostics; drug discovery, drug platform, development, and delivery; medical devices and equipment; surgical devices; therapeutics; pharma services; and specialty pharmaceuticals. Within sustainable and renewables, it invests in Vehicle Technology, Energy Generation and Storage, Ag Technology, Advanced Materials, and Industry 4.0. It also invests in educational services. The firm invests primarily in United States based companies and considers investment in the West Coast, Mid-Atlantic regions, Southeast and Midwest, particularly in the areas of software, biotech, and information services. The firm prefers to invest between $5 million and $200 million in equity per transactions. It invests generally between $1 million and $40 million in companies focused primarily on business services, communications, electronics, hardware, and healthcare services. The firm invests primarily in private companies but also have investments in public companies. For equity investments, the firm seeks to represent a controlling interest in its portfolio companies which may exceed 25% of the voting securities of such companies. The firm seeks to invest a limited portion of its assets in equipment-based loans to early-stage prospective portfolio companies. These loans are generally for amounts up to $3 million but may be up to $15 million for certain energy technology venture investments. The firm allows certain debt investments have the right to convert a portion of the debt investment into equity. It also co-invests with other private equity firms. The firm seeks to exit its investments through initial public offering, a private sale of equity interest to a third party, a merger or an acquisition of the company or a purchase of the equity position by the company or one of its stockholders. The firm has structured debt with warrants which typically have maturities of between two and seven years with an average of three years; senior debt with an investment horizon of less than three years; equipment loans with an investment horizon ranging from three to four years; and equity related securities with an investment horizon ranging from three to seven years. The firm prefers to invest through its balance sheet capital. The firm formerly known as Hercules Technology Growth Capital, Inc. Hercules Capital, Inc. was founded in December 2003 and is based in San Mateo, California with additional offices in North America and Europe.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Bluestein ScottChief Executive OfficerSep 26 '24Sale19.59100,0001,958,6402,161,207Sep 27 08:38 PM
SCOTT BLUESTEIN OfficerSep 26 '24Proposed Sale19.54100,0001,954,000Sep 26 04:23 PM
Theodosopoulos NikosDirectorAug 06 '24Buy18.031,60828,9975,613Aug 08 06:50 PM
Randhawa Paramjeet KDirectorAug 06 '24Buy18.072,89852,37815,972Aug 08 06:50 PM
Loo WadeDirectorAug 06 '24Buy18.545,645104,6768,746Aug 08 06:50 PM
CROWELL GAYLE ADirectorAug 06 '24Buy18.065,790104,59259,366Aug 08 06:49 PM
Aguirre DeAnneDirectorAug 06 '24Buy18.495,660104,66111,874Aug 08 06:49 PM
Fallon Thomas JDirectorAug 06 '24Buy18.335,723104,88592,400Aug 08 06:49 PM
CROWELL GAYLE ADirectorJun 25 '24Buy20.0570214,06753,576Jun 26 04:57 PM
BADAVAS ROBERT PDirectorJun 20 '24Option Exercise16.3413,300217,32217,534Jun 21 05:32 PM
BADAVAS ROBERT PDirectorJun 18 '24Option Exercise16.341,70027,7785,934Jun 21 05:32 PM
BADAVAS ROBERT PDirectorJun 20 '24Sale19.6913,300261,8924,234Jun 21 05:32 PM
BADAVAS ROBERT PDirectorJun 18 '24Sale19.601,70033,3204,234Jun 21 05:32 PM